MorphoSys AG
MPSYF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,229,194 | $456,783 | $1,106,769 | $3,055,965 |
| - Cash | $158,500 | $402,351 | $123,248 | $109,795 |
| + Debt | $635,932 | $339,459 | $325,791 | $318,202 |
| Enterprise Value | $1,706,627 | $393,892 | $1,309,312 | $3,264,372 |
| Revenue | $238,278 | $278,267 | $179,600 | $327,698 |
| % Growth | -14.4% | 54.9% | -45.2% | – |
| Gross Profit | $179,923 | $229,647 | $147,400 | $318,524 |
| % Margin | 75.5% | 82.5% | 82.1% | 97.2% |
| EBITDA | -$97,738 | $172,797 | -$331,124 | $127,738 |
| % Margin | -41% | 62.1% | -184.4% | 39% |
| Net Income | -$189,734 | -$151,058 | -$514,500 | $97,891 |
| % Margin | -79.6% | -54.3% | -286.5% | 29.9% |
| EPS Diluted | -5.53 | -4.42 | -15.4 | 2.97 |
| % Growth | -25.1% | 71.3% | -618.5% | – |
| Operating Cash Flow | -$295,837 | -$366,705 | -$481,445 | $35,270 |
| Capital Expenditures | -$2,873 | -$15,229 | -$26,156 | -$49,337 |
| Free Cash Flow | -$298,710 | -$381,934 | -$507,601 | -$14,067 |